(PharmaNewsWire.Com, June 07, 2018 ) Next generation sequencing (NGS) is the technology which is used to align millions of small fragments of DNA simultaneously that are capable of processing multiple DNA sequences in parallel. The arrival of rapid DNA sequencing methods has significantly enhanced biological and medical research and discovery.
The next generation sequencing market is anticipated to grow at a CAGR of 21.1% and reach US$ 26.5Bn by 2025. Increasing application of NGS in clinical diagnosis and research & development projects in the fields of metabolomics, proteomics, and transcriptomics are the major drivers which are likely to the boost the next generation sequencing market. NGS in precision medicine & biomarker discovery will add new opportunities for this market in the coming years.
The “Global Next Generation Sequencing Market Analysis to 2025” is a specialized and in-depth study of the next generation sequencing industry with a focus on the global market trend. The report aims to provide an overview of global next generation sequencing market with detailed market segmentation by product, technology, application, end-user, and geography. The global next generation sequencing market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the market.
Major Highlights of Next Generation Sequencing Market report:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the next generation sequencing market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the global next generation sequencing market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global next generation sequencing market based on product, technology, application, and end-user. It also provides market size and forecast till 2025 for overall next generation sequencing market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.
The report also includes the profiles of key next generation sequencing manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Illumina, Inc., Thermo Fisher Scientific, Inc., Qiagen N.V., Beijing Genomics Institute, Perkinelmer, Inc., F. Hoffmann-La Roche AG, Agilent Technologies, Eurofins Scientific, Oxford Nanopore Technologies, Ltd., Macrogen, Inc., and among others.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including: